Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.

Community pharmacists reveal preferences in content, method of TOC communication

20 Oct 2019

Transition of care (TOC) communication is very much needed, according to community pharmacists who also shared their preferences in the content and method of communication in a recent study.

To determine preferences in TOC communications, this cross-sectional study gathered data by means of an electronic survey of community pharmacists. The North Carolina Board of Pharmacy distributed the survey. Descriptive statistics was used to analyse the results.

A total of 343 community pharmacists responded to the electronic survey (response rate, 6.1 percent). Most of the respondents were working in an independent, single store (n=100; 29.2 percent) or national chain (n=100; 29.2 percent) pharmacy setting.

Via electronic health record was the most preferred method for a TOC communication (n=184; 63.0 percent). The commonly preferred contents of a TOC communication were as follows: active (n=274; 93.2 percent) and discontinued (n=254; 86.4 percent) medications and reason for hospitalization (n=250; 85.0 percent).

Lack of care coordination with community pharmacy (n=14; 35.0 percent), lack of support from other healthcare providers (n=9; 22.5 percent) and absence of compensation for providing the service (n=7; 17.5 percent) were the top three self-identified barriers to using a TOC communication.

In addition, most of the respondents (n=278; 97.5 percent) indicated that TOC communications would be useful if these were made available to them.

“Future research is warranted to implement TOC communications between a health system and community pharmacy,” the investigators said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.